Table 13 (abstract P210). See text for description
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
25 JIA patients with secondary LOE | 28 JIA patients without secondary LOE | |
|---|---|---|
median age (range) | 14.4 (6.0-27.0) years | 13.8 (7.6-21.5) years |
Sex | 21 female, 4 male | 18 female, 10 male |
median ADM dose (range) | 25.8 (10.7-58.8) mg/m2 every other week | 24.3 (6.6-37.1) mg/m2 every other week |
median duration of anti-TNF therapy (range) | 2.2 (0.2-6.0) years | 1.3 (0.2-10.4) years |
MTX comedication | 12/25 (48.0%) | 15/28 (53.6%) |
median MTX dose (range) | 10.0 (3.9-12.1) mg/m2 weekly | 10.8 (7.7-13.4) mg/m2 weekly |